[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_8682 

# __Advanced clinical trial methodologies__

## Risks linked to this technology

* [Investigation of new drugs for covid-19 therapy, such as tocilizumab and ace2-targeted treatments, may have unknown side effects and long-term impacts.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7129.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Vaccination development and distribution](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_66.md)

## This technology is mentioned by

* [Cirrincione_covid-19_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_441.md)

